Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Late life depression.

C G Gottfries1

  • 1Institute of Clinical Neuroscience Sahlgrenska, University Hospital Mölndal, Sweden.

European Archives of Psychiatry and Clinical Neuroscience
|February 5, 2002
PubMed
Summary
This summary is machine-generated.

Late life depression affects 15% of older adults and is underdiagnosed, increasing mortality risk. Comprehensive treatment, including SSRIs and support, improves outcomes significantly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HUMAN BRAIN LEVELS OF MONOAMINES AND THEIR METABOLITES. POSTMORTEM INVESTIGATIONS.

Acta psychiatrica Scandinavica·2017
Same author

Clinical and neurochemical aspects of diseases with cognitive impairment.

Reviews in the neurosciences·2011
Same author

Transmitter deficits in Alzheimer's disease.

Neurochemistry international·2010
Same author

Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2004
Same author

Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment.

Dementia and geriatric cognitive disorders·2003
Same author

[Sick listing--"disaster" or incompetence in statistics and diagnostics?].

Lakartidningen·2003
Same journal

Abnormal emotional intensity processing in individuals at clinical high risk for psychosis: evidence from event-related potentials.

European archives of psychiatry and clinical neuroscience·2026
Same journal

The role of attention in perceptual biases in patients with schizophrenia spectrum disorder and healthy controls.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of quetiapine on cognitive functioning in schizophrenia: evidence for the remyelination hypothesis?

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of xanomeline-trospium on the gut-lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and female mice.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Association of the red blood cell distribution width-to-albumin ratio with incident depression and depressive symptom trajectories in older adults.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.

European archives of psychiatry and clinical neuroscience·2026
See all related articles

Area of Science:

  • Gerontology
  • Psychiatry
  • Neuroscience

Background:

  • Late life depression (LLD) affects 15% of individuals aged 65+, significantly increasing mortality risk.
  • LLD is underdiagnosed and undertreated, with higher mortality rates following myocardial infarction and stroke.
  • Age-related brain changes, neurodegenerative disorders (e.g., Alzheimer's disease), and nutrient deficiencies (folic acid, vitamin B12) are risk factors.

Purpose of the Study:

  • To highlight the prevalence and risks of late life depression.
  • To discuss the heterogeneous etiology of depression in older adults.
  • To review current treatment strategies and their efficacy in the elderly population.

Main Methods:

  • Literature review of depression prevalence, risk factors, and treatment outcomes in older adults.

Related Experiment Videos

  • Analysis of epidemiological data on late life depression.
  • Evaluation of pharmacological (SSRIs) and non-pharmacological interventions.

    • Main Results:

    • Selective serotonin reuptuptake inhibitors (SSRIs) show a 65% response rate for depression and associated emotional disturbances.
    • Comprehensive treatment, integrating social and psychological support, achieves an 80-90% response rate.
    • Elderly patients face a higher risk of adverse events from depression medications.

    Conclusions:

    • Late life depression is a significant public health concern with serious consequences, including premature death.
    • SSRIs are effective treatments, but a multimodal approach combining medication with social and psychological support yields the best outcomes.
    • Early diagnosis and comprehensive management are crucial for improving the quality of life and reducing mortality in elderly individuals with depression.